Bragança Ana Carolina Costa, Alvares-da-Silva Mário Reis
Programa de Pós-Graduação em Gastroenterologia, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brasil.
Arq Gastroenterol. 2010 Jan-Mar;47(1):22-7. doi: 10.1590/s0004-28032010000100005.
Cirrhosis, diabetes mellitus, impaired glucose tolerance, insulin resistance, and protein calorie malnutrition are important issues in cirrhotic patients because they can increase the progression of liver disease and worsen its prognosis.
To determine the prevalence of diabetes mellitus, impaired glucose tolerance and insulin resistance in cirrhotic patients being evaluated for liver transplantation and their impacts on a 3-month follow-up, and to compare fasting glycemia and oral glucose tolerance test.
A cross-sectional study was performed in consecutively included adult patients. Diabetes mellitus was established through fasting glycemia and oral glucose tolerance test in diagnosing diabetes mellitus in this population. HOMA-IR and HOMA-beta indexes were calculated, and nutritional assessment was performed by subjective global assessment, anthropometry and handgrip strength through dynamometry.
Diabetes mellitus was found in 40 patients (64.5%), 9 (22.5%) of them by fasting glycemia and 31 (77.5%) of them by oral glucose tolerance test. Insulin resistance was found in 40 (69%) of the patients. There was no relationship between diabetes mellitus and the etiology of cirrhosis. Protein calorie malnutrition was diagnosed in a range from 3.22% to 45.2% by anthropometry, 58.1% by subjective global assessment and 88.7% by handgrip strength. Diabetes mellitus identified by oral glucose tolerance test was related significantly to a higher prevalence of infectious complications and deaths in a 3-month period (P = 0.017).
The prevalence of diabetes mellitus, impaired glucose tolerance, insulin resistance and protein calorie malnutrition is high in cirrhotic patients on the waiting list for liver transplantation. There were more infectious complications and/or deaths in a 3-month follow-up period in patients with diabetes mellitus diagnosed by oral glucose tolerance test. Oral glucose tolerance test seems to be indicated as a routine practice in this population.
肝硬化、糖尿病、糖耐量受损、胰岛素抵抗和蛋白质热量营养不良是肝硬化患者的重要问题,因为它们会加速肝病进展并使预后恶化。
确定接受肝移植评估的肝硬化患者中糖尿病、糖耐量受损和胰岛素抵抗的患病率及其对3个月随访的影响,并比较空腹血糖和口服葡萄糖耐量试验。
对连续纳入的成年患者进行横断面研究。通过空腹血糖和口服葡萄糖耐量试验来诊断该人群中的糖尿病。计算稳态模型评估的胰岛素抵抗指数(HOMA-IR)和稳态模型评估的β细胞功能指数(HOMA-β),并通过主观全面评定法、人体测量学和通过握力计测量的握力进行营养评估。
40例患者(64.5%)患有糖尿病,其中9例(22.5%)通过空腹血糖诊断,31例(77.5%)通过口服葡萄糖耐量试验诊断。40例(69%)患者存在胰岛素抵抗。糖尿病与肝硬化病因之间无关联。通过人体测量学诊断的蛋白质热量营养不良发生率为3.22%至45.2%,通过主观全面评定法诊断为58.1%,通过握力诊断为88.7%。通过口服葡萄糖耐量试验确诊的糖尿病与3个月内较高的感染并发症发生率和死亡率显著相关(P = 0.017)。
在等待肝移植的肝硬化患者中,糖尿病、糖耐量受损、胰岛素抵抗和蛋白质热量营养不良的患病率较高。通过口服葡萄糖耐量试验诊断为糖尿病的患者在3个月随访期内有更多的感染并发症和/或死亡。口服葡萄糖耐量试验似乎应作为该人群的常规检查。